ARYLETHINYL DERIVATIVES

FIELD: medicine, pharmaceutics.SUBSTANCE: invention refers to a new ethinyl derivative of formula I in the form of a racemic mixture or respective enanthiomer and/or optic isomer and/or stereoisomer or to a pharmaceutically acceptable salt of the above compounds formed by acid addition. The compound...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: SHTADLER KHAJNTS, GRIN LJUK, GUBA VOL'FGANG, ESHKE GEORG, LINDEMANN LOTAR, RICHCHI ANTONIO, RJUKHER DANIEHL, ZHOLIDON SINIZ, VIEJRA EHRIK
Format: Patent
Sprache:eng ; rus
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:FIELD: medicine, pharmaceutics.SUBSTANCE: invention refers to a new ethinyl derivative of formula I in the form of a racemic mixture or respective enanthiomer and/or optic isomer and/or stereoisomer or to a pharmaceutically acceptable salt of the above compounds formed by acid addition. The compounds are allosteric modulators of metabotropic glutamate receptor subtype 5 (mGluR5) and can find application in treating diseases mediated by mGluR5 action, wherein a disease is schizophrenia, cognitive disorders, fragile X syndrome or autism. In formula I,U is N or C(R); V is CH or N; W is CH or N; provided only one of the groups U, V or W is a nitrogen atom, Ris hydrogen, methyl or halogen; Y is -N(R)-, -O-, -C(R)(R)-, -CHO- or -CHS(O)-; Ris hydrogen or lower alkyl, whereas R/Rindependently represent hydrogen, hydroxy group, lower alkyl or lower alkoxy group; Ris phenyl or 5-6-merous heteroaryl containing 1-2 heteroatoms specified in nitrogen atoms, which can contain one or two substitutes specified in halogen or lower alkyl; R/Rindependently represent hydrogen, lower alkyl, hydroxy group, lower alkoxy group, C-C-cycloalkyl, CH-lower alkoxy group, or together with a carbon atom, to which they are attached, can form C-C-cycloalkyl, or a ring containing -CHOCH-; m is equal to 0, 1 or 2; if m is equal to 1, R/Rindependently represent hydrogen, lower alkyl, CH-lower alkoxy group, or together with a carbon atom, to which they are attached, can form C-C-cycloalkyl; or Rand Rtogether with a carbon atom, to which they are attached, can form C-cycloalkyl or a ring containing -(CH)OCH-; n is equal to 0 or 1; if n is equal to 1, R/Rindependently represent hydrogen, lower alkyl, CH-lower alkoxy group or together with a carbon atom, to which they are attached, can form C-C-cycloalkyl; Rand Rtogether with a carbon atom, to which they are attached, can form C-cycloalkyl; or if n is equal to 0, and Y is -N(R)-, then Rand Rtogether with a carbon atom and a nitrogen atom, to which they are attached, can form C-cycloalkyl; if n and m are equal to 0, then Rand Rwith a carbon atom, to which they are attached, can form C-cycloalkyl.EFFECT: producing the compounds mediated by mGluR5 action.28 cl, 1 tbl, 174 ex Изобретение относится к новому этинильному производному формулы I, в виде рацемической смеси или соответствующего энантиомера и/или оптического изомера и/или стереоизомера или к фармацевтически приемлемой соли указанных соединений, образованных добавлением кислоты. Соединения яв